A detailed history of Apollon Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 75,085 shares of BMY stock, worth $4.33 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
75,085
Previous 70,764 6.11%
Holding current value
$4.33 Million
Previous $2.94 Million 32.23%
% of portfolio
0.11%
Previous 0.09%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$39.66 - $51.75 $171,370 - $223,611
4,321 Added 6.11%
75,085 $3.89 Million
Q2 2024

Jul 19, 2024

SELL
$40.25 - $52.99 $397,348 - $523,117
-9,872 Reduced 12.24%
70,764 $2.94 Million
Q1 2024

May 02, 2024

BUY
$47.98 - $54.4 $138,902 - $157,488
2,895 Added 3.72%
80,636 $4.37 Million
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $170,892 - $203,921
3,525 Added 4.75%
77,741 $3.99 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $274,977 - $307,467
-4,750 Reduced 6.02%
74,216 $4.31 Million
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $209,223 - $232,310
3,284 Added 4.34%
78,966 $5.05 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $8,213 - $9,316
125 Added 0.17%
75,682 $5.25 Million
Q4 2022

Feb 15, 2023

BUY
$68.48 - $81.09 $114,361 - $135,420
1,670 Added 2.26%
75,557 $5.44 Million
Q3 2022

Nov 08, 2022

BUY
$0.13 - $76.84 $470 - $278,083
3,619 Added 5.15%
73,887 $5.25 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $303,914 - $334,716
4,185 Added 6.33%
70,268 $5.41 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $65,599 - $78,659
-1,067 Reduced 1.59%
66,083 $4.83 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $1.59 Million - $1.86 Million
29,702 Added 79.32%
67,150 $4.19 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $1.68 Million - $1.97 Million
28,366 Added 312.33%
37,448 $2.22 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $91,750 - $99,916
-1,482 Reduced 14.03%
9,082 $607,000
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $626,867 - $705,041
10,564 New
10,564 $667,000
Q4 2020

Jan 29, 2021

SELL
$57.74 - $65.43 $248,455 - $281,545
-4,303 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$57.43 - $63.64 $147,193 - $163,109
2,563 Added 147.3%
4,303 $259,000
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $95,386 - $111,516
1,740 New
1,740 $102,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Apollon Wealth Management, LLC Portfolio

Follow Apollon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.